Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Dimopoulos

Showing results (171-180 of 288) with videos related to

Pageof 29
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 21, 2007
Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experienceD Pectasides, G Fountzilas, G Aravantinos, et al.
Cancer Journal (Sudbury, Mass.)|October 9, 2007
CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: results of the HE22A99 trial of the Hellenic Cooperative Oncology GroupT Economopoulos, A Psyrri, M A Dimopoulos, et al.
Lung Cancer (Amsterdam, Netherlands)|August 19, 2007
Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology GroupD Pectasides, E Samantas, G Fountzilas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
A prospective study on lung toxicity in patients treated with gemcitabine and carboplatin: clinical, radiological and functional assessmentI Dimopoulou, E Efstathiou, A Samakovli, et al.
European Journal of Gynaecological Oncology|September 19, 2009
Clinicopathological features of primary fallopian tube carcinoma: a single institution experienceC A Papadimitriou, S Markaki, E Lianos, et al.
Cancer|June 15, 1997
A phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervixC A Papadimitriou, M A Dimopoulos, N Giannakoulis, et al.
Leukemia & Lymphoma|February 28, 2007
Renal failure in multiple myeloma: incidence, correlations, and prognostic significanceV Eleutherakis-Papaiakovou, A Bamias, D Gika, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistant paclitaxel-pretreated ovarian cancerG Aravantinos, M A Dimopoulos, P Kosmidis, et al.
Anticancer Research|August 10, 2002
Tumor volumetry as predictive and prognostic factor in the management of ovarian cancerE Andreopoulou, D Andreopoulos, K Adamidis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancerG Aravantinos, D Bafaloukos, G Fountzilas, et al.
Pageof 29

Showing results (171-180 of 288) with videos related to

Sort By:
Pageof 29
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 21, 2007
Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experienceD Pectasides, G Fountzilas, G Aravantinos, et al.
Cancer Journal (Sudbury, Mass.)|October 9, 2007
CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: results of the HE22A99 trial of the Hellenic Cooperative Oncology GroupT Economopoulos, A Psyrri, M A Dimopoulos, et al.
Lung Cancer (Amsterdam, Netherlands)|August 19, 2007
Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology GroupD Pectasides, E Samantas, G Fountzilas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
A prospective study on lung toxicity in patients treated with gemcitabine and carboplatin: clinical, radiological and functional assessmentI Dimopoulou, E Efstathiou, A Samakovli, et al.
European Journal of Gynaecological Oncology|September 19, 2009
Clinicopathological features of primary fallopian tube carcinoma: a single institution experienceC A Papadimitriou, S Markaki, E Lianos, et al.
Cancer|June 15, 1997
A phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervixC A Papadimitriou, M A Dimopoulos, N Giannakoulis, et al.
Leukemia & Lymphoma|February 28, 2007
Renal failure in multiple myeloma: incidence, correlations, and prognostic significanceV Eleutherakis-Papaiakovou, A Bamias, D Gika, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistant paclitaxel-pretreated ovarian cancerG Aravantinos, M A Dimopoulos, P Kosmidis, et al.
Anticancer Research|August 10, 2002
Tumor volumetry as predictive and prognostic factor in the management of ovarian cancerE Andreopoulou, D Andreopoulos, K Adamidis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancerG Aravantinos, D Bafaloukos, G Fountzilas, et al.
Pageof 29